The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review
Authors:
- Manmeet SinghMSManmeet Singh
- Joey R BangitJBJoey R Bangit
- Richard R BatsellRBRichard R Batsell
- 1 September 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 11 (9) , 633-647
Abstract
Insulin resistance is the main pathologic mechanism that links the constellation of clinical, metabolic and anthropometric traits with increased risk for cardiovascular disease and type II diabetes mellitus. These traits include hyperinsulinemia, impaired glucose intolerance, endothelial dysfunction, dyslipidemia, hypertension, and generalized and upper body fat redistribution. This cluster is often referred to as insulin resistance syndrome. The progression of insulin resistance to diabetes mellitus parallels the progression of endothelial dysfunction to atherosclerosis leading to cardiovascular disease and its complications. In fact, insulin resistance assessed by homeostasis model assessment (HOMA) has shown to be independently predictive of cardiovascular disease in several studies and one unit increase in insulin resistance is associated with a 5.4% increase in cardiovascular disease risk. This review article addresses the role of insulin resistance as a main causal factor in the development of metabolic syndrome and endothelial dysfunction, and its relationship with cardiovascular disease. In addition to this, we review the type of lifestyle modification and pharmacotherapy that could possibly ameliorate the effect of insulin resistance and reverse the disturbances in insulin, glucose and lipid metabolism.Keywords
This publication has 133 references indexed in Scilit:
- Selective PKC Beta Inhibition with Ruboxistaurin and Endothelial Function in Type-2 Diabetes MellitusCardiovascular Drugs and Therapy, 2008
- Adipokines, Insulin Resistance, and Coronary Artery CalcificationJACC, 2008
- Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitusDiabetologia, 2006
- Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistancePharmacology & Therapeutics, 2005
- Long-term effects of popular dietary approaches on weight loss and features of insulin resistanceInternational Journal of Obesity, 2005
- Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Insulin stimulates thyroid hormone receptor α gene expression in cultured bovine aortic endothelial cellsMolecular and Cellular Endocrinology, 1994
- Discrepancies in Lipolytic Activities Induced by β-Adrenoceptor Agonists in Human and Rat AdipocytesHormone and Metabolic Research, 1990
- Comparison of a High-Carbohydrate Diet with a High-Monounsaturated-Fat Diet in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988